Rojkjaer Lisa

CIK 00018464602 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001846460

Recent Transactions

31 trades

Award
RIGEL PHARMACEUTICALS INC$RIGL
Employee Stock Option (right to buy)
2025-09-15+7,394→ 7,394 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Employee Stock Option (right to buy)
2025-03-17+9,375→ 9,375 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2025-01-29+19,717→ 19,717 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Employee Stock Option (Right to Buy)
2025-01-29+14,788→ 14,788 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Employee Stock Option (right to buy)
2024-03-27+187,500→ 187,500 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2023-03-16+150,000→ 150,000 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-02-27$1.68/sh−2,156→ 48,087 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2023-02-25+4,127→ 50,243 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2023-02-25−4,127→ 37,146 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-11-28$2.72/sh−2,116→ 46,116 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-11-25+4,127→ 48,232 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-11-25−4,127→ 41,273 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-08-26$4.01/sh−2,190→ 44,105 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-08-25+4,127→ 46,295 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-08-25−4,127→ 45,400 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-05-26$1.90/sh−2,154→ 42,168 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-05-25+4,127→ 44,322 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-05-25−4,127→ 49,527 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2022-03-17+150,000→ 150,000 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-02-28$2.78/sh−2,395→ 40,195 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2022-02-25+4,127→ 53,654 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2022-02-25+4,127→ 42,590 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2021-11-29$4.82/sh−2,591→ 38,463 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2021-11-26$4.80/sh−1,950→ 41,054 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Restricted Stock Units
2021-11-25−8,254→ 57,781 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2021-11-25+8,254→ 43,004 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2021-05-11−2,061→ 30,956 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2021-05-11$3.58/sh+2,061→ 34,750 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2021-05-11$1.26/sh+32,689→ 32,689 total
Exercise/Conversion
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2021-05-11−32,689→ 98,069 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2021-03-26+126,890→ 126,890 total

Companies

Recent Filings

Address

RIGEL PHARMACEUTICALS, INC. 611 GATEWAY BLVD, SUITE 900

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov